Search Suggestions Antibody/fusion Protein Cell/gene Therapy Gmp Production Commercial Manufacturing Plasmid Virus Cell

CN
Advantages and Services

We provide customized product development transfer and manufacturing services. We guarantee the supply of drugs throughout the product lifecycle from multiple scales. We make contract drug manufacturing easy. In our extensive contract development and manufacturing services portfolio we use advanced technologies to quickly and conveniently deliver products.

Manufacturing operation and capacity

Altruist's Suzhou consists of a gene/cell therapy plant and a multiproduct antibody manufacturing plant. The total capacity for the antibody manufacturing plant is 60,000 liters, Altruist is the CDMO offering the largest number of commercial production batches. The facilities are designed in compliance with FDA, EMA and NMPA standards.

Gene Therapy/Cell Therapy Industrialization Service
  • 1,000m2

    Development and analytical platform

  • 1,000m2

    GMP manufacturing platform

With mature plasmid process development and GMP production capacity, we are available to help customers shorten the development cycle and quickly match IND/BLA.

Specific host strains can be selected according to the characteristics of different plasmid products, and the preparation and verification of seed banks can be completed following regulation requirements.

We have development experiences in plenty of projects, master cutting-edge technologies, which ensures the continuous and stable supply of production materials, and helps customers establish high-level plasmid preparation technology.

We can provide technology transfer and GMP production for smooth and efficient large-scale manufacturing.

Our teams have mature experience in providing lentivirus process development and GMP production services to help customers shorten the development cycle and quickly match IND/BLA requirements.

We also support the preparation and verification of cell bank.

We offer suspension-based processes or adherent processes at various scales with downstream purification to meet versatile requirements.

We can provide technology transfer and GMP production for smooth and efficient large-scale manufacturing.

Based on Quality-by-Design (QbD) concept , our process development platform includes not only cell-selection, cell-stimulation, cell-transduction, cell-expansion, cell-formulation services, but also process development services.

We can support the development and commercial production of CAR-T autologous product, NK cell therapeutic product and antibody combinational cell therapeutic product.

Support cell banking and characterization on bank-typed cell therapy products.

We provide full-stack assay method development and validation service for plasmids, viruses, cell therapy and gene therapy products, including batch release, stability studies, and product characterization, meeting customer filing needs and regulatory requirements.

We develop Critical Quality Attributes (CQA) for products based on Quality-by-Design (QbD) and provide comprehensive product quality research services for cell therapy and gene therapy.

Well-established platform of analytical method development and validation were built for plasmids, viruses, cell therapy and gene therapy products.

  • Plasmid Process Development Platform

    With mature plasmid process development and GMP production capacity, we are available to help customers shorten the development cycle and quickly match IND/BLA.

    Specific host strains can be selected according to the characteristics of different plasmid products, and the preparation and verification of seed banks can be completed following regulation requirements.

    We have development experiences in plenty of projects, master cutting-edge technologies, which ensures the continuous and stable supply of production materials, and helps customers establish high-level plasmid preparation technology.

    We can provide technology transfer and GMP production for smooth and efficient large-scale manufacturing.

  • Virus vector process development platform
  • Cell Process Development Platform
  • Analytical method development
Manufacturing Scale
  • 50 L E.coli culturing for plasmid manufacturing
  • 25 L culturing scale for virus manufacturing
  • At least 15 batches per month for cell therapy manufacturing


Wechat official account